Literature DB >> 30373155

Reply: On the Reporting of Odds Ratios and Risk Ratios, Nutrients 2018, 10, 10.

Elena Ricci1, Stefania Noli2, Sonia Cipriani3, Irene La Vecchia4, Francesca Chiaffarino5, Stefania Ferrari6, Paola Agnese Mauri7,8, Marco Reschini9, Luigi Fedele10,11, Fabio Parazzini12,13.   

Abstract

In response to the letter of Pace and Multani, in general, we cannot disagree with their considerations about the use of odds ratios, risk ratios, and rate ratios. [...].

Entities:  

Mesh:

Year:  2018        PMID: 30373155      PMCID: PMC6266880          DOI: 10.3390/nu10111581

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


Dear Editor,

In response to the letter of Pace and Multani, in general, we cannot disagree with their considerations about the use of odds ratios, risk ratios, and rate ratios. In the first version of the paper, our results were reported as odds ratios. Dr. Pace, one of the two reviewers, requested a new analysis more adequate to the prospective design of the study. Although all estimates were not far from unit and odds ratios were good estimates of both risk ratios and rate ratios, we agreed to that request and reported our results as rate ratios. It was not the first time that, in the framework of assisted reproduction techniques, rate ratios have been calculated instead of risk ratios. Such a use is due to the fact that, implicitly, a cycle of ART is considered a unit of time, thus leading to the consideration of the proportion of failure or success as a rate [1,2]. In such a situation, rate ratios and risk ratios are equal. The conclusions of our study did not change when we changed the analysis: Odds ratios and rate ratios for the three outcomes are reported in the Table 1. What we forgot to modify was the statistical methods, where “logistic regression” was left instead of “Cox regression”. For this reason, we apologize both to the Journal and to the readers.
Table 1

Odds ratios and rate ratios for the three outcomes.

ImplantationClinical PregnancyLive Birth
Women AOR (95% CI) ARR (95% CI) AOR (95% CI) ARR (95% CI) AOR (95% CI) ARR (95% CI)
Caffeine intake
1st tertile111111
2nd tertile1.42 (0.62–3.23)1.34 (0.64–2.79)1.23 (0.66–2.29)1.07 (0.76–1.50)1.50 (0.74–3.02)1.09 (0.79–1.50)
3rd tertile0.86 (0.34–2.19)0.90 (0.38–2.10)0.97 (0.52–1.84)1.00 (0.70–1.43)0.94 (0.47–1.88)0.99 (0.71–1.40)
>90° percentile §0.49 (0.12–2.05)0.58 (0.16–2.04)0.80 (0.25–2.59)0.96 (0.51–1.80)0.90 (0.27–3.06)0.99 (0.54–1.84)
Men
Caffeine intake
1st tertile111111
2nd tertile1.86 (0.82–4.23)1.64 (0.78–3.44)1.02 (0.56–1.87)1.01 (0.72–1.42)1.11 (0.56–2.19)1.02 (0.75–1.41)
3rd tertile0.74 (0.29–1.92)0.78 (0.32–1.87)1.28 (0.68–2.43)1.07 (0.76–1.52)1.02 (0.51–2.05)1.00 (0.72–1.40)
>90° percentile §0.68 (0.14–3.39)0.73 (0.17–3.16)1.48 (0.47–4.61)1.12 (0.59–2.14)1.00 (0.29–3.46)0.98 (0.54–1.83)
Combined intake (W-M)
Low-low111111
Low-high0.75 (0.29–1.91)0.79 (0.34–1.85)1.12 (0.54–2.32)1.03 (0.71–1.50)1.51 (0.67–3.40)1.09 (0.76–1.55)
High-low1.28 (0.51–3.22)1.22 (0.53–2.78)0.85 (0.41–1.74)0.95 (0.64–1.42)1.24 (0.55–2.80)1.06 (0.73–1.54)
High-high0.54 (0.20–1.44)0.60 (0.24–1.48)0.70 (0.36–1.36)0.89 (0.61–1.30)0.74 (0.36–1.52)0.93 (0.65–1.33)

AOR: adjusted odds ratio; ARR: adjusted rate ratio; CI: confidence interval; W-M: women-men; § as compared to 10th percentile.

We should have been more explicit about these aspects of the statistical methodology, but, as the revised version was approved and published, we thought that it was clear enough. Presumably, Dr. Pace did not even see the second version, or he would have asked a further revision.
  2 in total

1.  Perinatal outcomes in multifetal pregnancy following fetal reduction.

Authors:  Neda Razaz; Tehila Avitan; Joseph Ting; Tracy Pressey; K S Joseph
Journal:  CMAJ       Date:  2017-05-08       Impact factor: 8.262

2.  Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome.

Authors:  Zi-Jiang Chen; Yuhua Shi; Yun Sun; Bo Zhang; Xiaoyan Liang; Yunxia Cao; Jing Yang; Jiayin Liu; Daimin Wei; Ning Weng; Lifeng Tian; Cuifang Hao; Dongzi Yang; Feng Zhou; Juanzi Shi; Yongle Xu; Jing Li; Junhao Yan; Yingying Qin; Han Zhao; Heping Zhang; Richard S Legro
Journal:  N Engl J Med       Date:  2016-08-11       Impact factor: 91.245

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.